Bokus
Paul H. Johnson, Paul H. Johnson - RNA Interference, Inbunden

Inbunden, Engelska, 2011

RNA Interference

Application to Drug Discovery and Challenges to Pharmaceutical Development

Av Paul H. Johnson, Paul H. Johnson

1687 kr

Beställningsvara. Skickas inom 7-10 vardagar. Fri frakt över 249 kr.

Fler format och utgåvor

Beskrivning
RNA Interference: Application to Drug Discovery and Challenges to Pharmaceutical Development provides a general overview of this rapidly emerging field, with a strong emphasis on issues and aspects that are important to a drug development team. The first part covers more general background of RNA interference and its application in drug discovery. In the second part, the book addresses siRNA (small interfering RNA), a pharmaceutically potent form, and its use and delivery in therapeutics along with manufacturing and delivery aspects.
Produktinformation
  • Utgivningsdatum: 2011-02-15
  • Mått: 160 x 239 x 23 mm
  • Vikt: 590 g
  • Format: Inbunden
  • Språk: Engelska
  • Antal sidor: 336
  • Förlag: John Wiley & Sons Inc
  • Medarbetare: John J. Rossi
  • ISBN: 9780471771517
Utforska kategorier
Mer om författaren

PAUL H. JOHNSON, PhD, is a cofounder and Chief Scientific Officer at PhaseRx, Inc. He is the author of numerous scientific papers and patents, and was the recipient of the 2007 Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery.

Recensioner i media

"This is an accessible book that approaches the goal of therapeutic RNAi delivery from a technological viewpoint. Chapter organization and figure presentation allow for interrupted reading without disrupting the flow. Cell and molecular biologists will find both interesting details and practical methods to improve the preclinical applicability of a research project. While therapeutic RNAi is still largely in the development stage, this book promotes a mindset to continue the search for effective delivery strategies." (Doody's, 7 October 2011)

Betyg & recensioner

0 recensioner

Inga recensioner tillgängliga.